Haleon plc (HLN)

Healthcare · Drug Manufacturers Specialty Generic · NYSE

Haleon plc (HLN) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $44.17B, a trailing price-to-earnings ratio of 23.3 and a free-cash-flow yield of 6.6%. Over the most recent reported fiscal year, revenue declined 1.8% and free cash flow per share grew 14.0%.

Market cap	$44.17B
Trailing P/E	23.3
FCF yield	6.6%
Revenue growth (YoY)	-1.8%
EPS growth (YoY)	—
FCF/share growth (YoY)	+14.0%
Exchange	NYSE
Sector	Healthcare
Industry	Drug Manufacturers Specialty Generic

Explore live HLN data on Nama Insights →

Recent Congressional trades

Haleon plc trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Valerie Hoyle	House	Sell	$1,001 - $15,000	Sep 23, 2025
Valerie Hoyle	House	Buy	$1,001 - $15,000	Sep 11, 2025
Lisa McClain	House	Buy	$1,001 - $15,000	Aug 13, 2025
Josh Gottheimer	House	Buy	$1,001 - $15,000	Jun 5, 2024
Josh Gottheimer	House	Buy	$1,001 - $15,000	Aug 8, 2023
Daniel Goldman	House	Buy	$1,001 - $15,000	Mar 1, 2023